Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2024 Dec;51(6):639-651.
doi: 10.1007/s10928-023-09894-4. Epub 2023 Nov 12.

Comparison of monoclonal antibody disposition predictions using different physiologically based pharmacokinetic modelling platforms

Affiliations
Comparative Study

Comparison of monoclonal antibody disposition predictions using different physiologically based pharmacokinetic modelling platforms

Pieter-Jan De Sutter et al. J Pharmacokinet Pharmacodyn. 2024 Dec.

Abstract

Physiologically based pharmacokinetic (PBPK) models can be used to leverage physiological and in vitro data to predict monoclonal antibody (mAb) concentrations in serum and tissues. However, it is currently not known how consistent predictions of mAb disposition are across PBPK modelling platforms. In this work PBPK simulations of IgG, adalimumab and infliximab were compared between three platforms (Simcyp, PK-Sim, and GastroPlus). Accuracy of predicted serum and tissue concentrations was assessed using observed data collected from the literature. Physiological and mAb related input parameters were also compared and sensitivity analyses were carried out to evaluate model behavior when input values were altered. Differences in serum kinetics of IgG between platforms were minimal for a dose of 1 mg/kg, but became more noticeable at higher dosages (> 100 mg/kg) and when reference (healthy) physiological input values were altered. Predicted serum concentrations of both adalimumab and infliximab were comparable across platforms, but were noticeably higher than observed values. Tissue concentrations differed remarkably between the platforms, both for total- and interstitial fluid (ISF) concentrations. The accuracy of total tissue concentrations was within a three-fold of observed values for all tissues, except for brain tissue concentrations, which were overpredicted. Predictions of tissue ISF concentrations were less accurate and were best captured by GastroPlus. Overall, these simulations show that the different PBPK platforms generally predict similar mAb serum concentrations, but variable tissue concentrations. Caution is therefore warranted when PBPK models are used to simulate effect site tissue concentrations of mAbs without data to verify the predictions.

Keywords: Adalimumab; Biodistribution; IgG; Infliximab; Monoclonal antibodies; Physiologically based pharmacokinetics.

PubMed Disclaimer

Conflict of interest statement

Declarations. Conflict of interest: The authors report no conflict of interest.

Similar articles

Cited by

References

    1. Tang Y, Li X, Cao Y (2021) Which factors matter the most? Revisiting and dissecting antibody therapeutic doses. Drug Discovery Today 26:1980–1990. https://doi.org/10.1016/j.drudis.2021.04.022 - DOI - PubMed - PMC
    1. Shah DK, Betts AM (2013) Antibody biodistribution coefficients. MAbs 5:297–305. https://doi.org/10.4161/mabs.23684 - DOI - PubMed - PMC
    1. Glassman PM, Abuqayyas L, Balthasar JP (2015) Assessments of antibody biodistribution. J Clin Pharmacol 55:S29–S38. https://doi.org/10.1002/jcph.365 - DOI - PubMed
    1. Garg A, Balthasar JP (2007) Physiologically-based pharmacokinetic (PBPK) model to predict IgG tissue kinetics in wild-type and FcRn-knockout mice. J Pharmacokinet Pharmacodyn 34:687–709. https://doi.org/10.1007/s10928-007-9065-1 - DOI - PubMed
    1. Lobo ED, Hansen RJ, Balthasar JP (2004) Antibody pharmacokinetics and pharmacodynamics. J Pharm Sci 93:2645–2668. https://doi.org/10.1002/jps.20178 - DOI - PubMed

Publication types

MeSH terms

LinkOut - more resources